Vanguard Group’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $646M | Buy |
|
|||||
|
2025
Q1 | $747M | Sell |
|
|||||
|
2024
Q4 | $743M | Sell |
|
|||||
|
2024
Q3 | $680M | Sell |
|
|||||
|
2024
Q2 | $675M | Sell |
|
|||||
|
2024
Q1 | $777M | Buy |
|
|||||
|
2023
Q4 | $783M | Sell |
|
|||||
|
2023
Q3 | $826M | Buy |
|
|||||
|
2023
Q2 | $787M | Buy |
|
|||||
|
2023
Q1 | $904M | Buy |
|
|||||
|
2022
Q4 | $964M | Buy |
|
|||||
|
2022
Q3 | $785M | Buy |
|
|||||
|
2022
Q2 | $898M | Buy |
|
|||||
|
2022
Q1 | $872M | Buy |
|
|||||
|
2021
Q4 | $706M | Buy |
|
|||||
|
2021
Q3 | $713M | Sell |
|
|||||
|
2021
Q2 | $974M | Buy |
|
|||||
|
2021
Q1 | $828M | Buy |
|
|||||
|
2020
Q4 | $805M | Buy |
|
|||||
|
2020
Q3 | $681M | Sell |
|
|||||
|
2020
Q2 | $544M | Sell |
|
|||||
|
2020
Q1 | $514M | Buy |
|
|||||
|
2019
Q4 | $753M | Buy |
|
|||||
|
2019
Q3 | $642M | Buy |
|
|||||
|
2019
Q2 | $704M | Sell |
|
|||||
|
2019
Q1 | $725M | Buy |
|
|||||
|
2018
Q4 | $625M | Buy |
|
|||||
|
2018
Q3 | $821M | Buy |
|
|||||
|
2018
Q2 | $837M | Buy |
|
|||||
|
2018
Q1 | $723M | Buy |
|
|||||
|
2017
Q4 | $642M | Buy |
|
|||||
|
2017
Q3 | $693M | Buy |
|
|||||
|
2017
Q2 | $727M | Buy |
|
|||||
|
2017
Q1 | $656M | Buy |
|
|||||
|
2016
Q4 | $477M | Buy |
|
|||||
|
2016
Q3 | $521M | Buy |
|
|||||
|
2016
Q2 | $596M | Buy |
|
|||||
|
2016
Q1 | $550M | Buy |
|
|||||
|
2015
Q4 | $578M | Buy |
|
|||||
|
2015
Q3 | $526M | Buy |
|
|||||
|
2015
Q2 | $682M | Buy |
|
|||||
|
2015
Q1 | $642M | Buy |
|
|||||
|
2014
Q4 | $569M | Buy |
|
|||||
|
2014
Q3 | $525M | Buy |
|
|||||
|
2014
Q2 | $456M | Sell |
|
|||||
|
2014
Q1 | $439M | Buy |
|
|||||
|
2013
Q4 | $365M | Buy |
|
|||||
|
2013
Q3 | $257M | Buy |
|
|||||
|
2013
Q2 | $180M | Buy |
|